NCT00003441View on ClinicalTrials.gov

Irofulven in Treating Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

November 8, 2000

Study Completion Date

November 8, 2000

Conditions
Colorectal Cancer
Interventions
DRUG

Irofulven (MGI-114)

IV over 5 minutes daily for 5 consecutive days. Courses repeated every 28 days. Minimum treatment period is 2 courses.

Trial Locations (1)

77030

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00003441 - Irofulven in Treating Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter